As previously discussed, Fra-2 transgenic mice display a pro-fibrotic phenotype characterized by a dramatic activation of fibroblasts and macrophages, eventually promoting systemic sclerosis, lung fibrosis, vascular remodeling, and inflammation [25–27, 32, 33]. The gene discussed is FOSL2; the disease is systemic sclerosis.